ESP TECHNOLOGY LIMITED

Active Ruthin

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
E

ESP TECHNOLOGY LIMITED

Research and experimental development on biotechnology

Founded 21 Jul 2011 Active Ruthin, Wales 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

ENSCO 877 LIMITED 21 Jul 2011 — 19 Aug 2011
ENSCO 877 LIMITED 21 Jul 2011 — 19 Aug 2011
Accounts Submitted 28 Apr 2021 Next due 1 May 2022 50 months overdue
Confirmation Submitted 28 Sept 2020 Next due 4 Aug 2021 59 months overdue
Net assets £-462K £26K 2020 year on year
Total assets £127K £24K 2020 year on year
Total Liabilities £588K £2K 2020 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Barnfold Llanfair.D.C Ruthin Denbighsire LL15 2RU Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ESP TECHNOLOGY LIMITED (07713552), an active company based in Ruthin, Wales. Incorporated 21 Jul 2011. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2020
Type Total Exemption Full
Next accounts 31 December 2021
Due by 30 September 2022 9 months

Net Assets, Total Assets & Total Liabilities (2013–2020)

Cash in Bank

N/A

Net Assets

-£461.70k

Increased by £26.32k (+5%)

Total Liabilities

£588.25k

Decreased by £1.97k (-0%)

Turnover

N/A

Employees

N/A

Decreased by 2 (-100%)

Debt Ratio

465%

Decreased by 113 (-20%)

Financial History

Revenue, profit, EBITDA and key financial figures

2020
Dec Year End
2019
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (10)

Nwf (biomedical) Lp
25.3%
Christopher John Underwood
22.3%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Nwf (biomedical) Lp

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,significant Influence Or Control As Firm

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Feb 2022DissolutionDissolved Compulsory Strike Off Suspended
11 Jan 2022GazetteGazette Notice Compulsory
28 Apr 2021AccountsAnnual accounts made up to 1 Aug 2020
8 Apr 2021OfficersTermination of Christopher John Underwood as director on 23 Mar 2021
28 Sept 2020Confirmation StatementConfirmation statement made on 21 Jul 2020 with no updates
15 Feb 2022 Dissolution

Dissolved Compulsory Strike Off Suspended

11 Jan 2022 Gazette

Gazette Notice Compulsory

28 Apr 2021 Accounts

Annual accounts made up to 1 Aug 2020

8 Apr 2021 Officers

Termination of Christopher John Underwood as director on 23 Mar 2021

28 Sept 2020 Confirmation Statement

Confirmation statement made on 21 Jul 2020 with no updates

Recent Activity

Latest Activity

Dissolved Compulsory Strike Off Suspended

4 years ago on 15 Feb 2022

Gazette Notice Compulsory

4 years ago on 11 Jan 2022

Annual accounts made up to 1 Aug 2020

5 years ago on 28 Apr 2021

Termination of Christopher John Underwood as director on 23 Mar 2021

5 years ago on 8 Apr 2021

Confirmation statement made on 21 Jul 2020 with no updates

5 years ago on 28 Sept 2020